Johns Hopkins ABX Guide
Ethionamide
INDICATIONS
FDA
FDA
- Tuberculosis (in patients w/ active M. tuberculosis resistant to isoniazid or rifampin, or when there is intolerance to other drugs)
- FDA indication is not a statement of the drug’s current role in TB therapy.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 12, 2026
Citation
Soto, Caitlin, and Edina Avdic. "Ethionamide." Johns Hopkins ABX Guide, The Johns Hopkins University, 2026. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540217/all/Ethionamide.
Soto C, Avdic E. Ethionamide. Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540217/all/Ethionamide. Accessed September 21, 2026.
Soto, C., & Avdic, E. (2026). Ethionamide. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540217/all/Ethionamide
Soto C, Avdic E. Ethionamide [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. [cited 2026 September 21]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540217/all/Ethionamide.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ethionamide
ID - 540217
A1 - Soto,Caitlin,PharmD, BCIDP
AU - Avdic,Edina,Pharm.D.
Y1 - 2026/09/12/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540217/all/Ethionamide
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
